Bactolife
PrivateLast Round
Series B
Jan 6, 2026
Est. Valuation
$23.26M
Total Funding Raised
$81.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bactolife is a biotechnology company that develops proprietary Binding Protein ingredients designed to fortify the gut microbiome and reduce the risk of gastrointestinal infections in humans and animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bactolife Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bactolife Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 6, 2026 | ||||
| Series A | Aug 8, 2023 | ||||
| Grant | Aug 30, 2022 | ||||
| Seed | Apr 19, 2021 |
Key People
Founding team and executive leadership
Bactolife Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Selfinvest | Seed, Series A |
| Athos KG | Series B, Series A |
| Gates Family Foundation | Series B |
| Gates Foundation | Series B, Grant, Series A |
| Novo Holdings | Series B, Series A, Seed |
| The Bill & Melinda Gates Foundation Trust | Grant, Series A |
| Novoseeds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2027
Binding Proteins product to target mass market from 2027.
- Jan 8, 2026
Partnering with AceBiome to launch a new probiotic-binding protein product in Korea.
Bactolife Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bactolife's valuation, stock price, and market status.